SCHEMBL30607282

CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.67

Predicted protein targets (top 4)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	7/20	0.67

▸	ECE1	P42892	1/20	0.67

▸	MUS81	Q96NY9	1/20	0.67

▸	IL23R	Q5VWK5	13/20	0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29433266	0.92	GLP1R (0.69)	GLP1RECE1MUS81IL23R
SCHEMBL31000941	0.91	GLP1R (0.71)	GLP1RECE1MUS81IL23R
SCHEMBL30607465	0.90	GLP1R (0.71)	GLP1RECE1MUS81
SCHEMBL31275967	0.89	RXFP1 (0.65)	GLP1RECE1MUS81IL23R
SCHEMBL29558511	0.89	GLP1R (0.77)	GLP1RECE1MUS81
SCHEMBL29479855	0.89	GLP1R (0.69)	GLP1RECE1MUS81IL23R
SCHEMBL30658330	0.89	GLP1R (0.70)	GLP1RECE1MUS81
SCHEMBL30658278	0.88	GLP1R (0.77)	GLP1RECE1MUS81
SCHEMBL30883240	0.88	GLP1R (0.71)	GLP1RECE1MUS81IL23R
SCHEMBL30906474	0.88	GLP1R (0.67)	GLP1RECE1MUS81IL23R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed